GlucoTrack, Inc., a medical device company, designs, develops, and commercializes non-invasive glucose monitoring devices for use by people suffering from diabetes and pre-diabetics in Israel and internationally. It develops GlucoTrack glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Or Yehuda, Israel.

Employees - 6, CEO - Mr. Paul V. Goode Ph.D., Sector - Healthcare, Country - IL, Market Cap - 6.24M

Altman ZScore(max is 10): -264.9, Piotroski Score(max is 10): 3, Working Capital: $-3969000, Total Assets: $826000, Retained Earnings: $-122356000, EBIT: -13097000, Total Liabilities: $4848000, Revenue: $42000

- Current Price $0.29 - Analyst Target Price $-